Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hematol., Transfus. Cell Ther. (Impr.) ; 43(3): 243-248, July-Sept. 2021. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1346265

RESUMO

Abstract Introduction: Sickle cell anemia (SCA) is a Mendelian disorder with a heterogeneous clinical course. The reasons for this phenotypic diversity are not entirely established, but it is known that high fetal hemoglobin levels lead to a milder course of the disease. Additionally, genetic variants in the intergenic region HBS1L-MYB promote high levels of fetal hemoglobin into adulthood. Objective: In the present study, we investigated the HMIP1 C-839A (rs9376092) polymorphism, located at the HBS1L-MYB intergenic region block 1, in SCA patients. Method: We analyzed 299 SCA patients followed in two reference centers in Brazil. The HMIP1 C-839A (rs9376092) genotypes were determined by allele specific polymerase chain reactions. Clinical and laboratory data were obtained from patient interviews and medical records. Results: The median fetal hemoglobin levels were higher in patients with the HMIP1 C-839A (rs9376092) AA genotype (CC = 6.4%, CA = 5.6% and AA = 8.6%), but this difference did not reach significance (p = 0.194). No association between HMIP1 C-839A (rs9376092) genotypes and other clinical and laboratorial features was detected (p > 0.05). Conclusion: In summary, our data could not support the previously related association between the HMIP1 C-893A (rs9376092) polymorphism and differential fetal hemoglobin levels.


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Hemoglobina Fetal , Anemia Falciforme , Polimorfismo Genético
2.
Rev. bras. hematol. hemoter ; 30(1): 12-17, jan.-fev. 2008. graf, tab
Artigo em Português | LILACS | ID: lil-485327

RESUMO

O diagnóstico neonatal de hemoglobinopatias permite a melhoria na qualidade de vida do doente com a implementação de medidas profiláticas, acompanhamento clínico e aconselhamento genético. Objetivou-se no presente estudo o diagnóstico das hemoglobinas variantes e talassemias em amostras de sangue de cordão umbilical de neonatos da região noroeste do estado de São Paulo por Cromatografia Líquida de Alta Performance (HPLC), associada a procedimentos eletroforéticos, bioquímicos e citológicos, visando adaptar a melhor metodologia de análise à freqüência dos defeitos de hemoglobina na população brasileira. Foram analisadas 3.048 amostras de janeiro de 2001 a dezembro de 2002, e 13,12 por cento apresentaram alterações de hemoglobinas, sendo 1,84 por cento com presença de Hb S; 0,6 por cento com Hb C; 0,65 por cento com resultados sugestivos de beta talassemia e 9,48 por cento sugestivos de alfa talassemia. Dentre as hemoglobinas anormais encontradas, 0,33 por cento das amostras apresentaram resultados discordantes nas metodologias aplicadas. A HPLC mostrou-se eficiente para a identificação de variantes de hemoglobinas e permitiu a análise de grande número de amostras em curto espaço de tempo e agilidade nas triagens. Entretanto, foi necessário associar outros métodos de análise para a caracterização das formas talassêmicas.


The neonatal diagnosis hemoglobinopathies improves the quality of life by prophylactic measures and genetic counseling. The diagnosis of variant hemoglobins and thalassemias was considered in the present study. Cord blood samples of newborn babies from the northwestern region of São Paulo state were analyzed by High Performance Liquid Chromatography (HPLC) associated with electrophoretic, biochemical and cytologic procedures aiming to adapt the best methodology to analyze the frequency of hemoglobin defects in the Brazilian population. Three thousand and forty-eight samples were analyzed from January 2001 to December 2002 with 13.12 percent presenting hemoglobin alterations; 1.84 percent had Hb S; 0.6 percent had Hb C; 0.65 percent were suggestive of thalassemia beta and 9.48 percent were suggestive of thalassemia alpha. Among the abnormal hemoglobins, 0.33 percent of the samples presented different results in the methodologies used. HPLC was efficient to identify variant hemoglobins and enable the analysis of several samples in a short period of time with agility in screenin. However, an association of other methods was necessary for the characterization of the thalassemic forms.


Assuntos
Humanos , Masculino , Feminino , Lactente , Técnicas de Laboratório Clínico , Hemoglobinopatias/diagnóstico , Hemoglobinopatias/prevenção & controle , Programas de Rastreamento , Triagem Neonatal , Talassemia/diagnóstico , Talassemia/prevenção & controle , Testes Hematológicos/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...